Ascelia Pharma AB (publ) (STO:ACE)
Sweden · Delayed Price · Currency is SEK 4.850
+0.050 (1.04%)
Aug 14, 2025, 5:29 PM CET
Ascelia Pharma AB Market Cap
Ascelia Pharma AB has a market cap or net worth of 556.92 million as of August 14, 2025. Its market cap has increased by 255.17% in one year.
Market Cap
556.92M
Enterprise Value
526.86M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
4.85
Market Cap Chart
Since March 13, 2019, Ascelia Pharma AB's market cap has decreased from 562.35M to 556.92M, a decrease of -0.96%. That is a compound annual growth rate of -0.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 556.92M | 98.45% |
| Dec 30, 2024 | 280.63M | 146.68% |
| Dec 29, 2023 | 113.76M | -77.38% |
| Dec 30, 2022 | 503.00M | -49.95% |
| Dec 30, 2021 | 1.00B | -36.78% |
| Dec 30, 2020 | 1.59B | 186.78% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 13, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 94.08B |
| Sectra AB | 67.17B |
| Getinge AB | 54.11B |
| Medicover AB | 40.46B |
| Asker Healthcare Group AB | 39.30B |
| Camurus AB | 38.15B |
| Bonesupport Holding AB | 20.44B |
| AddLife AB | 20.03B |